Heerma Peter's Planned Sale of Travere Therapeutics Common Stock

Heerma Peter, an officer of Travere Therapeutics, Inc., has filed a Form 144 notice indicating the planned sale of 2,662 shares of common stock. The shares were acquired through restricted stock vesting on 10/01/2020 and 02/04/2021. The sale is expected to occur on 10/28/2025, with an aggregate market value of $79,860. The shares will be sold through Fidelity Brokerage Services LLC. There were no securities sold in the past three months. The filing is related to the planned sale of securities under Rule 144.